Skip to content

Donate

  • Home
  • About
    • Our EHA Board
    • Our Members
    • Our Partners
    • About us
      • History
      • Stronger Together
      • Presidents Report 2024
      • 2025 | General Assembly minutes
      • Constitution
      • Policy Towards Pharma
      • Funding Sources 2024
      • 2023 | EMA eligible organisation
    • Huntington’s Disease
    • Huntington Community
  • News
  • HTAs
  • Our Projects
    • Moving Forward
    • HD Trial Finder
    • HD – CAB
    • Huntington Academy
    • HD-R-READY
  • Online Resources
  • Videos
    • Webinars
    • Personal Stories
    • Trials & Research
  • Community Spotlight
  • EHA Conference 2025 | Bucharest
  • Events
    • 2023 | Belgium
    • 2023 | Glasgow
    • 2022 | Bologna
    • 2019 | Bucharest
    • 2018 | Vienna
    • 2017 | Sofia
  • Contact Us
  • Home
  • About
    • Our EHA Board
    • Our Members
    • Our Partners
    • About us
      • History
      • Stronger Together
      • Presidents Report 2024
      • 2025 | General Assembly minutes
      • Constitution
      • Policy Towards Pharma
      • Funding Sources 2024
      • 2023 | EMA eligible organisation
    • Huntington’s Disease
    • Huntington Community
  • News
  • HTAs
  • Our Projects
    • Moving Forward
    • HD Trial Finder
    • HD – CAB
    • Huntington Academy
    • HD-R-READY
  • Online Resources
  • Videos
    • Webinars
    • Personal Stories
    • Trials & Research
  • Community Spotlight
  • EHA Conference 2025 | Bucharest
  • Events
    • 2023 | Belgium
    • 2023 | Glasgow
    • 2022 | Bologna
    • 2019 | Bucharest
    • 2018 | Vienna
    • 2017 | Sofia
  • Contact Us
Menu here

DAY 3

  • Serena Hung, Senior Director at Wave Life Sciences giving an introduction to the biotechnology company's huntingtin lowering approach.
  • Associate Director at uniQure, Melvin Evers, speaking about gene therapy and Huntington's disease.
  • Panel discussion. Left to right: Baltazar Gomez (Novartis), Melvin Evers (uniQure), Scott Schobel (Roche Pharmaceuticals), Serena Hung (Wave Life Sciences) and Ralf Reilmann.
  • Left to right: Baltazar Gomez (Novartis), Melvin Evers (uniQure), Scott Schobel (Roche Pharmaceuticals) and Serena Hung (Wave Life Sciences)
  • Winning photo of EHA and Orphan People Russia's photo exhibition.
  • An amazing group of people coming all the way from Portugal!
  • Goodbye hugs.
  • Naim from Turkey at his first (but not last) Huntington's disease conference.
  • Left to right: Valerie Pihet, Naim and Alice Rivieres.
  • Left to right: Matty Ellison, Valerie Pihet, Naim and Alice Rivieres.
  • Attendees from Romania.
  • Attendees from Romania.

MENU

MENU

  • Home
  • About
    • Our EHA Board
    • Our Members
    • Our Partners
    • About us
      • History
      • Stronger Together
      • Presidents Report 2024
      • 2025 | General Assembly minutes
      • Constitution
      • Policy Towards Pharma
      • Funding Sources 2024
      • 2023 | EMA eligible organisation
    • Huntington’s Disease
    • Huntington Community
  • News
  • HTAs
  • Our Projects
    • Moving Forward
    • HD Trial Finder
    • HD – CAB
    • Huntington Academy
    • HD-R-READY
  • Online Resources
  • Videos
    • Webinars
    • Personal Stories
    • Trials & Research
  • Community Spotlight
  • EHA Conference 2025 | Bucharest
  • Events
    • 2023 | Belgium
    • 2023 | Glasgow
    • 2022 | Bologna
    • 2019 | Bucharest
    • 2018 | Vienna
    • 2017 | Sofia
  • Contact Us